Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RITE AID, PRESIDENT GRASS INDICTMENTS BY OHIO GRAND JURY

Executive Summary

RITE AID, PRESIDENT GRASS INDICTMENTS BY OHIO GRAND JURY are on hold while the Ohio Court of Common Pleas for Cuyahoga County weighs the merits of a complaint by Rite Aid against the prosecuting attorney's office handling the case. The indictments, which were unsealed by the court on Aug. 1, charge that Grass attempted to bribe a member of the Ohio Board of Pharmacy. The court ruled Aug. 2 that "upon motion of the defendants and for good cause shown . . . further processing and/or service of the indictment . . . is restrained until further order." * Rite Aid claimed in a motion filed with the court in June that the amount and type of publicity offered by the Cuyahoga County prosecuting attorney's office with regard to the bribery charges should lead the court to consider dismissal of the prosecutor, John Corrigan. The assistant prosecuting attorney, William Caine, is also named in the filing. Martin Grass was arrested April 27, while handing a company check for approximately $ 33,000 to Melvin Wilczynski, a member of the Ohio Pharmacy Board and a consultant and former employee of Peoples Drug. Grass was charged with one count of bribery. In a press release issued shortly after the arrest, the prosecuting attorney said that the payment was part of a "bribe" intended to remove Wilczynski from the Ohio board and replace him with "a pharmacist of Rite Aid's choosing." The grand jury indictment was handed up on June 14 but kept under seal while allegations against state government officials in connection with the charges are reportedly being investigated. Rite Aid has disclosed that its management met with at least one member of the state government with regard to the administration and enforcement of pharmacy laws in Ohio. Rite Aid currently operates approximately 349 outlets in the state. Rite Aid had no formal response to the indictment, but said it stood by earlier statements that the allegations are "without merit" and that the firm and Grass will be "exonerated" as "facts become public." Rite Aid also continues to deny "any wrongful intent in any criminal activities." The company has asserted that the check to Wilczinski was a payment made in exchange for a corporate release settling the consultant agreement which Rite Aid assumed when it acquired the Peoples Drug chain.

You may also be interested in...



Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance

FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials

Shire Hopes To Sow Future Deals With $50M Venture Fund

Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth

Latest Headlines
See All
UsernamePublicRestriction

Register

PS016055

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel